CORRECTION: Applied UV's Systems Proven to Kill Candida Auris, an Emerging Multi-Drug-Resistant Fungus
Applied UV, Inc. (AUVI)
Company Research
Source: Accesswire
The following replaces and corrects the release issued on October 19, 2021:Candida Auris is a pathogenic disease commonly acquired in hospitals or long-term care facilitiesCenters for Disease Control and Prevention ("CDC") has stated that 30-60% of people with C. auris bloodstream infections dieCDC currently considers Candidiasis as one of the most significant infectious diseases in the world today.Currently, there is no vaccine or preventative measures taken for C. auris for humansGrowing global scientific research emphasis recommending Governments consider improving indoor air quality to support the defense of future airborne pathogenic pandemicsRecent test results and acquisitions support expanded commercial adoption coupled with new consumer product launch utilizing Key InfluencersMOUNT VERNON, NY / ACCESSWIRE / November 5, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultravi
Show less
Read more
Impact Snapshot
Event Time:
AUVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AUVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AUVI alerts
High impacting Applied UV, Inc. news events
Weekly update
A roundup of the hottest topics
AUVI
News
- Aegis Capital Corp. Acted as Exclusive Placement Agent on a $2.76 Million Registered Direct and Private Placement Priced at the Market for Applied UV, Inc. (NASDAQ: AUVI) [Yahoo! Finance]Yahoo! Finance
- Aegis Capital Corp. Acted as Exclusive Placement Agent on a $2.76 Million Registered Direct and Private Placement Priced at the Market for Applied UV, Inc. (NASDAQ: AUVI)Accesswire
- Applied UV, Inc. Announces Closing of $2.76 Million Registered Direct and Private Placement [Yahoo! Finance]Yahoo! Finance
- Applied UV, Inc. Announces Closing of $2.76 Million Registered Direct and Private PlacementGlobeNewswire
- Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules [Yahoo! Finance]Yahoo! Finance
AUVI
Sec Filings
- 4/23/24 - Form S-1/A
- 4/22/24 - Form DEF
- 4/19/24 - Form 8-K
- AUVI's page on the SEC website